Effect of Bombyx mori, Antheraea Yamamai and Antheraea pernyi Silk Protein in Skin Fibroblast Cell Proliferation After Injury

피부세포 증식에 관여하는 실크단백질 탐색

  • Han, Sang-Mi (Dept. of Agricultural Biology, NIAST, RDA) ;
  • Lee, Kwang-Gill (Dept. of Agricultural Biology, NIAST, RDA) ;
  • Yeo, Joo-Hong (Dept. of Agricultural Biology, NIAST, RDA) ;
  • Kweon, Hae-Yong (Dept. of Agricultural Biology, NIAST, RDA) ;
  • Woo, Soon-Ok (Dept. of Agricultural Biology, NIAST, RDA) ;
  • Baek, Ha-Ju (Dept. of Wasterwater Analysis, KyongsangBuk-Do Govement Public Institute of Health & Environment) ;
  • Park, Kwan-Kyu (Dept. of Pathology, Catholic University of Daegu School of Medicine)
  • 한상미 (농업과학기술원 농업생물부) ;
  • 이광길 (농업과학기술원 농업생물부) ;
  • 여주홍 (농업과학기술원 농업생물부) ;
  • 권해용 (농업과학기술원 농업생물부) ;
  • 우순옥 (농업과학기술원 농업생물부) ;
  • 백하주 (경상북도보건환경연구원) ;
  • 박관규 (대구가톨릭대학교 병리학교실)
  • Published : 2004.12.01

Abstract

We have studied the effect of silk proteins to the cell proliferation of human skin fibroblast cells (CCD-986sk) after injury. Silk proteins were extracted treatment with enzyme or NaOH solution from raw silk and culled-cocoon shell of Bombyx mori, Antheraea yamamai and A. pernyi. The cell proliferation after in vitro injury are increased in treatment by Bombyx mori (BM-1,2), Antheraea yamami (AY-1,2) and A. pernyi (AP-1,2). The silk protein fractions-treated cells exhibited proliferation in a dose dependent between $0.1\;{\mu}g/ml$ and $10\;{\mu}g/ml$. But, the macrophage, RAW 264. 7 cell viability was unaffected by the silk protein fractions by MTT assay. The molecular weights of the silk protein fractions were from 300-600 to 900-1500. These results results that the silk protein fractions may function through skin fibroblast proliferation.

가잠과 천잠 및 작잠의 실크 단백질 분획물로부터 피부섬유아세포에 대한 증식 효과를 알아본 결과 다음과 같은 결과를 얻을 수 있었다. 1. 가잠 및 천${\cdot}$작잠 단백질로부터 다양한 분자량대의 실크 단백질을 순수 분리 분획화 하여 사람 피부세포(human skin fibroblast; CCD-986sk)에 기계적 상처를 준 후 처리한 결과, 평균분자량(Mw)이 300-500 및 950-1500 분획군이 세포 증식에 뛰어난 효과가 있음을 확인${\cdot}$선발하였다. 2. 가잠의 경우 평균 분자량 590(BM-1), 1400(BM-2)에서, 천잠은 340(AY-1), 940(AY-2), 작잠에서는 300(AP-1), 1440(AP-2)에서 $10\;{\mu}g/ml$의 농도로 처리했을 경우 피부섬유 아세포의 증식이 무처리구에 비하여 40% 이상의 증식 효과를 갖았다. 또한 유효 농도 범위에서 대식세포인 RAW 264.7 세포에 대해서는 세포독성을 지니지 않았다. 3. 아미노산 조성에 있어 저분자량 AY-1 분획의 전아미노산 및 유리아미노산은 Tyr 함량이 매우 높게(25-48 g/100g)나타났으며, 작잠의 저분자 분획인 AP-1에서는 Lys 함량이 높게(5.2 g/100g) 나타남을 확인하였다. 4. 동일한 실크 단백질일 경우 저분자량 분획물에서 피부 세포 증식에 좀 더 효과적이였다.

Keywords

References

  1. 권해용,이광길,여주홍,박용환 (2003) 질산아연에 의한 작잠견피 브로인의 용해와 특성. 한잠학지, 45(2): 121-125
  2. 여주홍,이광길,이용우,남진,김선여 (1999) 용해조건에 따른 견단백질 조성 변화. 분석곽회지, 12(4): 306-311
  3. 여주홍,이광길,권해용,우순옥,한상미,이용우,김진일,김성수,山村 城 (2004) 견 피브로인 효소 가수분해물의 동물 인지기능 향상 효과. 한잠학지, 46(1): 23-27
  4. 이광길,여주홍,이용우,권해용,김종호 (2001) 세리신 단백질의 생리활성과 피부친화성 탐색. 한잠학지, 45(2): 109-115
  5. Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn and E. Ruoslahti (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor $\beta$1. Nature, 346: 371-374
  6. Broekelmann, T. J., A. H. Limper, T. V. Colby and J. A. McDonald (1991) Transforming growth factor $\beta$1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci., 88: 6642-6646
  7. Bullard, K. M., D. L. Cass, M. J. Banda and N. Scott Adzick (1997) Transforming growth factor beta-1 decreases interstitial collagenase in healing human fetal skin. J Pediatr Surg., 32(7): 1023-1102
  8. Eisinger, M., S. Sadan, I. A. Silver and R. B. Flick (1998) Growth regulation of skin cells by epidermal cell-derived factors: implications for wound healing. Proc. Natl. Acad. Sci.,85: 1937-1941
  9. Kato, N., S. Sato, A. Yamanaka, H. Yamada, N. Fuwa and M. Nomura (1998) Silk Protein, Sericin, inhibits Lipid Peroxidation and Tyrosinase Activity. Biosci. Biotech. Biochem., 62(1): 145-147
  10. Kaufman, T., P. Nathan, M. Levin, P. A. Hebda, E. H. Eichenlaub and B. korol (1985) Drug-loaded synthetic dressings: effect on contraction, epithelialization, and collagen synthesis of deep second-degress experimental burns, Ann. Plast. Surg., 14: 420-427
  11. Kuroyanagi, Y. E. Kim and N. Shioya (1991) Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine. J care. Rehabil., 12: 106-115
  12. Natalia, G., K. Kugathasan, C. N. Chesterman and L. M. Khachigian (2001) Early growth factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury. J. cellular Biochemistry 81: 523-534
  13. McCauley, R., Y. L. V. Chopra, D. Herndon and M. Robbson (1994) Cytoprotection of human dermal fibroblasts against silver sulfadiazine using recombinant growth factor. J Surg. Res., 56: 378-384
  14. Piscatelli, S. J., B. M. Michaels, P. Gregory, R. W Jennings, M. T. Longaker, M. R. Harrison and J. W. Siebert (1994) Fetal fibroblast contraction of collagen matrices in vitro; the effects of epidermal growth factor and transforming growth factor-$\beta$. Ann. Plast. Surg., 33: 38-45
  15. Shah, M., D. M. Foreman and M. W. J. Ferguson (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor-$\beta$. Lancet, 339: 213-224
  16. Shinozaki, M., S. Kawara, N. Hayashi, T. Kakinuma, A. Igarashi and R. D. Rosenberg (1997) Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor-$\beta$ : simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun., 237: 292-296
  17. Yeo, J. H., K. G. Lee, H. S. Lee, Y. W. Lee and S. Y. Kim (2000) Studies on PVA/Chitosan/Fibroin blend sponge sheets: Preparation and wound healing efficts in rats. Int. J. Indust. Entomol., 1(1): 59-64